Search Articles
SAN JOSE – Kyowa Hakko Kirin Co. and Biowa Inc. claim Aragen Bioscience and Transposagen Biopharmaceuticals’ use of Chinese hamster ovary cell lines to develop vaccines and therapies violates three patents, in Federal Court.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.